Advisers to the Food and Drug Administration met Thursday to help decide which variant of the virus that causes COVID should ...

The FDA may limit annual COVID-19 boosters to high-risk groups unless clinical trials prove benefits for healthy adults under ...

WASHINGTON (AP) — A government report released on Thursday covering wide swaths of American health and wellness reflects some ...

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...

Some members of the Vaccines and Related Biologics Products Advisory Committee worried that a strain change would require new ...

The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being ...

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be ...

The U.S. government has not yet made its official recommendations for who should be able to get COVID booster shots this fall ...

After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...

FDA now requires Pfizer and Moderna COVID-19 vaccines to carry expanded warning labels about risks of myocarditis and pericarditis ...

Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.